CHMP4C as a Novel Marker Regulates Prostate Cancer Progression through Cycle Pathways and Contributes to Immunotherapy

Researchers investigated the expression and clinical prognosis of charged multivesicular protein (CHMP) 4C and explored its potential regulatory mechanism in prostate cancer.